Skip to main content

Table 1 Patients characteristic

From: Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial

Variable

Sertraline plus deanxit

Sertraline plus placebo

p value

(N = 38)

(N = 37)

Age(yr)

   

Mean ± SD

62.8 ± 13.1

61.5 ± 13.3

NS

Gender(%)

   

Male

13(34.2%)

15(40.5%)

NS

Female

25(65.8%)

22(59.5%)

NS

BMI(body mass index)

   

Mean ± SD

28.3 ± 4.1

28.0 ± 4.3

NS

Employment status

   

Employed

14(36.8%)

12(32.4%)

NS

Unemployed

24(63.2%)

25(67.6%)

NS

Categories of chronic diseases

   

Single hypertension

7

7

NS

Single diabetes

8

8

NS

Single chronic headache

6

5(droup out = 1)

NS

Single Parkinson’s disease

5(droup out = 1)

6

NS

chronic obstructive pulmonary diseases

5

5

NS

co-morbidity two or more chronic somatic disease

8

7(droup out = 1)

NS

Baseline score of HAMD

   

Mean ± SD

31.6 ± 4.9

33.3 ± 5.1

NS

Baseline score of HAMA

   

Mean ± SD

22.39 ± 4.3

23.0 ± 4.5

NS

  1. Notes: NS = No Significant.